Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Specialty PACS Market, by Deployment Model
1.4.2 Asia Pacific Specialty PACS Market, by Type
1.4.3 Asia Pacific Specialty PACS Market, by End User
1.4.4 Asia Pacific Specialty PACS Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnership, Collaborations and Agreements: 2017, Jul – 2022, Jan) Leading Players
Chapter 4. Asia Pacific Specialty PACS Market by Deployment Model
4.1 Asia Pacific On premises Market by Country
4.2 Asia Pacific Cloud-based Market by Country
Chapter 5. Asia Pacific Specialty PACS Market by Type
5.1 Asia Pacific Radiology PACS Market by Country
5.2 Asia Pacific Orthopedics PACS Market by Country
5.3 Asia Pacific Oncology PACS Market by Country
5.4 Asia Pacific Pathology PACS Market by Country
5.5 Asia Pacific Ophthalmology PACS Market by Country
5.6 Asia Pacific Women’s health PACS Market by Country
5.7 Asia Pacific Other Type Market by Country
Chapter 6. Asia Pacific Specialty PACS Market by End User
6.1 Asia Pacific Hospitals & Clinics Market by Country
6.2 Asia Pacific Ambulatory Surgical Centers Market by Country
6.3 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Specialty PACS Market by Country
7.1 China Specialty PACS Market
7.1.1 China Specialty PACS Market by Deployment Model
7.1.2 China Specialty PACS Market by Type
7.1.3 China Specialty PACS Market by End User
7.2 Japan Specialty PACS Market
7.2.1 Japan Specialty PACS Market by Deployment Model
7.2.2 Japan Specialty PACS Market by Type
7.2.3 Japan Specialty PACS Market by End User
7.3 India Specialty PACS Market
7.3.1 India Specialty PACS Market by Deployment Model
7.3.2 India Specialty PACS Market by Type
7.3.3 India Specialty PACS Market by End User
7.4 South Korea Specialty PACS Market
7.4.1 South Korea Specialty PACS Market by Deployment Model
7.4.2 South Korea Specialty PACS Market by Type
7.4.3 South Korea Specialty PACS Market by End User
7.5 Singapore Specialty PACS Market
7.5.1 Singapore Specialty PACS Market by Deployment Model
7.5.2 Singapore Specialty PACS Market by Type
7.5.3 Singapore Specialty PACS Market by End User
7.6 Malaysia Specialty PACS Market
7.6.1 Malaysia Specialty PACS Market by Deployment Model
7.6.2 Malaysia Specialty PACS Market by Type
7.6.3 Malaysia Specialty PACS Market by End User
7.7 Rest of Asia Pacific Specialty PACS Market
7.7.1 Rest of Asia Pacific Specialty PACS Market by Deployment Model
7.7.2 Rest of Asia Pacific Specialty PACS Market by Type
7.7.3 Rest of Asia Pacific Specialty PACS Market by End User
Chapter 8. Company Profiles
8.1 Novarad Enterprise Healthcare Solutions
8.1.1 Company Overview
8.1.2 Recent Strategies and developments:
8.1.2.1 Partnerships, Collaborations and Agreements:
8.1.2.2 Product Launches and Product Expansions:
8.2 Escalon Medical Corp.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.3 IBM Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent Strategies and developments:
8.3.5.1 Partnerships, Collaborations and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 Siemens AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent Strategies and developments:
8.4.5.1 Partnerships, Collaborations and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.5.3 Acquisitions and Mergers:
8.4.6 SWOT Analysis
8.5 Canon, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent Strategies and developments:
8.5.5.1 Partnerships, Collaborations and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 INFINITT Healthcare Co. Ltd.
8.6.1 Company Overview
8.6.2 Recent Strategies and developments:
8.6.2.1 Partnerships, Collaborations and Agreements:
8.7 Koninklijke Philips N.V.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent Strategies and developments:
8.7.5.1 Product Launches and Product Expansions:
8.7.5.2 Acquisitions and Mergers:
8.8 McKesson Corporation
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 Research & Development Expense
8.9 Carestream Health, Inc. (Onex Corporation)
8.9.1 Company Overview
8.10. Topcon Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Recent Strategies and developments:
8.10.4.1 Partnerships, Collaborations and Agreements:
8.10.4.2 Acquisitions and Mergers:
Unique Offerings 
